Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Risk factor management: the cardiologist's perspective

¹Guy's Hospital, London, UK.

British Journal of Clinical Practice. Supplement

|January 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stop: the medical and human rights scandal in Bahrain.

International journal of clinical practice·2011

Same author

Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2011

Same author

Transferable SAFT-VR models for the calculation of the fluid phase equilibria in reactive mixtures of carbon dioxide, water, and n-alkylamines in the context of carbon capture.

The journal of physical chemistry. B·2011

Same author

Structural and functional failure of TVT by trimming of the extruded edge.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011

Same author

Cholesteric order in systems of helical Yukawa rods.

Journal of physics. Condensed matter : an Institute of Physics journal·2011

Same author

Communicating about death and dying.

International journal of clinical practice·2011

Same journal

Treatment of dyslipidaemias with fluvastatin.

British journal of clinical practice. Supplement·2009

Same journal

Lipoprotein(a) as a marker for coronary heart disease.

British journal of clinical practice. Supplement·2009

Same journal

Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.

British journal of clinical practice. Supplement·2009

Same journal

Risk factor management: the cardiologist's perspective.

British journal of clinical practice. Supplement·2009

Same journal

Fluvastatin in combination with other lipid-lowering agents.

British journal of clinical practice. Supplement·2009

Same journal

The patient at risk: who should we be treating?

British journal of clinical practice. Supplement·2009

See all related articles

Managing cardiovascular disease requires a comprehensive approach to risk factors like smoking, hypertension, and hyperlipidemia. Effective prevention strategies, tailored to the individual, are crucial for slowing disease progression and improving patient outcomes.

Area of Science:

Cardiology
Preventive Medicine
Public Health

Background:

Cardiovascular disease management often focuses on secondary prevention after disease onset.
Primary prevention is less contentious but crucial for slowing disease progression.
Risk factors are additive and require a holistic, individualized assessment.

Purpose of the Study:

To emphasize the importance of comprehensive risk factor management in cardiovascular disease.
To highlight the role of prevention in disease management over interventional procedures.
To address the educational gap in risk factor management for both patients and cardiologists.

Main Methods:

Review of established cardiovascular risk factors and their additive nature.
Discussion of the interplay between different risk factors and their management.

Related Experiment Videos

Analysis of the limitations of interventional cardiology versus preventive strategies.

Emphasis on the team-based approach involving the patient as a key member.

Main Results:

Cardiovascular risk factors, including smoking, hypertension, and hyperlipidemia, are additive and require aggressive management.
Preventive strategies, focusing on detail and individual tailoring, are more effective in slowing disease progression than interventions like angioplasty.
Therapeutic interventions must consider potential adverse metabolic effects and be individualized.
A significant educational deficit exists among patients and cardiologists regarding risk factor management.

Conclusions:

A proactive, team-based approach to cardiovascular disease prevention, focusing on individual risk factors, is essential.
Detailed attention to prevention, tailored to the patient, can induce disease regression.
Addressing the educational needs of both patients and healthcare providers is vital for effective cardiovascular risk management.